跳至主要内容
临床试验/NCT03286088
NCT03286088已完成不适用

Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection

Philips Electronics Nederland B.V. acting through Philips CTO organization2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
Central diastolic and systolic blood pressures

研究概览

简要总结

The study primarily aims to collect standard of care clinical data in a wide spectrum of simple to complex mitral valve regurgitation (MVR) cases to validate a post-processing stand-alone software prototype (QFlow), developed by Philips Research Paris (Medisys).

Investigator does not intervene in the care of the patient, but simply collects standard of care images and measurements that are needed for the validation of the investigational software.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • both genders
  • age between 18 and 85 years old (adult, senior)
  • sinus rhythm
  • hHemodynamic stable
  • mitral valve regurgitation (MVR) of any grade i.e., from mild to severe as determined by assessment of a qualifying TransThoracic Echocardiography (TTE) exam at Saint-Luc University Hospital
  • scheduled for TransEsophageal Echocardiography (TEE) at Saint-Luc University Hospital, as part of the subject's routine standard of care
  • subjects has functional capacity to give written informed consent

排除标准

  • pregnancy
  • subject lacks functional capacity to give written informed consent belongs to a vulnerable population per investigator's judgment or subject has any kind of disorder that compromises his/her ability to give written informed consent and/or to comply with study procedures
  • Among the120 subjects, there will be three (3) sub-groups as follows:
  • a first sub-group (A) of 50 subjects with all inclusion criteria and none of the exclusion criteria
  • a second sub-group (B) of 50 subjects with additional inclusion criterion: scheduled for cardiac Magnetic Resonance (cMR), as part of the subject's routine standard of care
  • a third sub-group (C) of 20 subjects with additional inclusion criterion: scheduled for MitraClip transcatheter mitral valve repair (MitraClip) procedure as part of the subject's routine standard of care

结局指标

主要结局

Central diastolic and systolic blood pressures

时间窗: Day 1

images and measurements

次要结局

未报告次要终点

研究者

发起方
Philips Electronics Nederland B.V. acting through Philips CTO organization
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验